日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Advanced Technologies in Extracellular Vesicle Biosensing: Platforms, Standardization, and Clinical Translation

细胞外囊泡生物传感先进技术：平台、标准化和临床转化

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules31020227
Choi, Seong-Jun; Choi, Jaewon; Kim, Jin; Kim, Si-Hoon; Cho, Hyung-Geun; Lim, Min-Yeong; Chae, Sehyun; Lim, Kwang Suk; Ha, Suk-Jin; Kim, Hyun-Ouk
囊泡
细胞生物学
发表日期：2026
文献求助 收藏

Surface Engineering of Natural Killer Cells with Lipid-Based Antibody Capture Platform for Targeted Chemoimmunotherapy

利用基于脂质的抗体捕获平台对自然杀伤细胞进行表面工程改造，以实现靶向化疗免疫治疗

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17101285
Lim, Su Yeon; Kim, Yeongbeom; Kim, Hongbin; Han, Seungmin; Yun, Jina; Kim, Hyun-Ouk; Ha, Suk-Jin; Chae, Sehyun; Won, Young-Wook; Lim, Kwang Suk
自然杀伤细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Polymer- and Lipid-Based Nanostructures for Wound Healing with Barrier-Resolved Design

基于聚合物和脂质的纳米结构在屏障解析设计下的伤口愈合应用

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17111501
Cho, Eunsoo; Yun, Soyeon; Lee, Subin; Kim, Minse; Choi, Jaewon; Choi, Sun Eun; Lim, Kwang Suk; Ha, Suk-Jin; Yun, Jang-Hyuk; Kim, Hyun-Ouk
发表日期：2025
文献求助 收藏

Physiological Barriers to Nucleic Acid Therapeutics and Engineering Strategies for Lipid Nanoparticle Design, Optimization, and Clinical Translation

核酸疗法的生理障碍及脂质纳米颗粒设计、优化和临床转化的工程策略

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17101309
Kim, Yerim; Park, Jisu; Choi, Jaewon; Kim, Minse; Seo, Gyeongsu; Kim, Jeongeun; Park, Jeong-Ann; Lim, Kwang Suk; Ha, Suk-Jin; Kim, Hyun-Ouk
发表日期：2025
文献求助 收藏

Advances in PCL, PLA, and PLGA-Based Technologies for Anticancer Drug Delivery

基于PCL、PLA和PLGA的抗癌药物递送技术进展

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17101354
Kim, Yeongbeom; Kwak, Jaewoo; Lim, Minyeong; Lim, Su Yeon; Chae, Sehyun; Ha, Suk-Jin; Won, Young-Wook; Kim, Hyun-Ouk; Lim, Kwang Suk
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Combination Strategies with HSP90 Inhibitors in Cancer Therapy: Mechanisms, Challenges, and Future Perspectives

癌症治疗中HSP90抑制剂的联合治疗策略：机制、挑战和未来展望

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph18081083
Kim, Yeongbeom; Lim, Su Yeon; Kim, Hyun-Ouk; Ha, Suk-Jin; Park, Jeong-Ann; Won, Young-Wook; Chae, Sehyun; Lim, Kwang Suk
肿瘤
HSP90
肿瘤免疫
发表日期：2025
文献求助 收藏

Upregulation of the gluconeogenesis pathway was observed by Kluyveromyces marxianus KDH1, mitigating glucose catabolite repression.

克鲁维酵母 KDH1 可上调糖异生途径，从而减轻葡萄糖分解代谢阻遏

期刊:Food Science and Biotechnology
影响因子:3.1
doi:10.1007/s10068-024-01670-5
Kwon Deok-Ho, Lee Sol Hee, Lee Jang-Sub, Ha Suk-Jin
代谢
发表日期：2025
文献求助 收藏

Recent advances in microbial and enzymatic engineering for the biodegradation of micro- and nanoplastics

微生物和酶工程在微纳米塑料生物降解方面的最新进展

期刊:RSC Advances
影响因子:4.6
doi:10.1039/d4ra00844h
Choi, Jaewon; Kim, Hongbin; Ahn, Yu-Rim; Kim, Minse; Yu, Seona; Kim, Nanhyeon; Lim, Su Yeon; Park, Jeong-Ann; Ha, Suk-Jin; Lim, Kwang Suk; Kim, Hyun-Ouk
微生物学
发表日期：2024
文献求助 收藏

Overexpression of Mutant Galactose Permease (ScGal2_N376F) Effective for Utilization of Glucose/Xylose or Glucose/ Galactose Mixture by Engineered Kluyveromyces marxianus

过表达突变型半乳糖渗透酶 (ScGal2_N376F) 可有效促进工程化克鲁维酵母利用葡萄糖/木糖或葡萄糖/半乳糖混合物

期刊:Journal of Microbiology and Biotechnology
影响因子:3.1
doi:10.4014/jmb.2008.08035
Kwon, Deok-Ho; Kim, Saet-Byeol; Park, Jae-Bum; Ha, Suk-Jin
发表日期：2020
文献求助 收藏

Single amino acid substitutions in HXT2.4 from Scheffersomyces stipitis lead to improved cellobiose fermentation by engineered Saccharomyces cerevisiae.

通过对 Scheffersomyces stipitis 的 HXT2.4 进行单个氨基酸替换，可以改善基因工程改造的酿酒酵母对纤维二糖的发酵能力

期刊:Applied and Environmental Microbiology
影响因子:3.7
doi:10.1128/AEM.03253-12
Ha Suk-Jin, Kim Heejin, Lin Yuping, Jang Myoung-Uoon, Galazka Jonathan M, Kim Tae-Jip, Cate Jamie H D, Jin Yong-Su
发表日期：2013
文献求助 收藏